Morning Briefing
Summaries of health policy coverage from major news organizations
Reducing Commodity Costs For ARVs Could Mean Providing Treatment To Millions More People
"Reducing commodity costs [for antiretroviral drugs] by a mere five to 10 percent can represent hundreds of millions of dollars in savings for the global community. In turn these savings translate into millions of more patients who can receive access to life-saving treatment," David de Ferranti, president of Results for Development Institute (R4D), and Kanika Bahl, managing director at R4D, write in a Huffington Post opinion piece. They discuss a strategic plan for increasing access to and lowering the cost of antiretroviral drugs (ARVs) that R4D developed for the Global Fund to Fight AIDS, Tuberculosis and Malaria.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
